SHPHF (Sihuan Pharmaceutical Holdings Group) Interest Coverage: 2.28 (As of Dec. 2025) — 99% Below Median


SHPHF Sihuan Pharmaceutical Holdings Group Ltd SHPHF
52 GF Score
Price $0.13
GF Value $0.17
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Sihuan Pharmaceutical Holdings Group Interest Coverage?

Sihuan Pharmaceutical Holdings Group SHPHF 52 Interest Coverage is 2.28 as of Dec. 2025, which is 99% below its 10-year median of 275.67. GuruFocus rates SHPHF with a GF Score™ of 52/100 and a GF Value™ of $0.17 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 685 Drug Manufacturers companies, Sihuan Pharmaceutical Holdings Group ranks worse than 86.57% on this metric.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Sihuan Pharmaceutical Holdings Group's Operating Income for the six months ended in Dec. 2025 was $31.3 Mil. Sihuan Pharmaceutical Holdings Group's Interest Expense for the six months ended in Dec. 2025 was $-13.7 Mil. Sihuan Pharmaceutical Holdings Group's interest coverage for the quarter that ended in Dec. 2025 was 2.28. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for Sihuan Pharmaceutical Holdings Group's Interest Coverage or its related term are showing as below:

SHPHF' s Interest Coverage Range Over the Past 10 Years
Min: 1.86   Med: 275.67   Max: 30529.29
Current: 1.86


SHPHF's Interest Coverage is ranked worse than
86.57% of 685 companies
in the Drug Manufacturers industry
Industry Median: 12.78 vs SHPHF: 1.86

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Sihuan Pharmaceutical Holdings Group  (OTCPK:SHPHF) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Sihuan Pharmaceutical Holdings Group Interest Coverage Related Terms


Sihuan Pharmaceutical Holdings Group Interest Coverage Historical Data

* Premium members only.

The historical data trend for Sihuan Pharmaceutical Holdings Group's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Sihuan Pharmaceutical Holdings Group Interest Coverage Chart

Sihuan Pharmaceutical Holdings Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Interest Coverage
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.52 0.00 0.00 0.00 1.86

Sihuan Pharmaceutical Holdings Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 1.47 2.28

SHPHF vs ZTS: Interest Coverage Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Sihuan Pharmaceutical Holdings Group's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sihuan Pharmaceutical Holdings Group Interest Coverage vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sihuan Pharmaceutical Holdings Group's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Sihuan Pharmaceutical Holdings Group's Interest Coverage falls into.


SHPHF
52GF Score
Sihuan Pharmaceutical Holdings Group Ltd SHPHF
Interest Coverage is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sihuan Pharmaceutical Holdings Group Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Sihuan Pharmaceutical Holdings Group's Interest Coverage for the fiscal year that ended in Dec. 2025 is calculated as

Here, for the fiscal year that ended in Dec. 2025, Sihuan Pharmaceutical Holdings Group's Interest Expense was $-28.6 Mil. Its Operating Income was $53.3 Mil. And its Long-Term Debt & Capital Lease Obligation was $104.3 Mil.

Interest Coverage=-1* Operating Income (A: Dec. 2025 )/Interest Expense (A: Dec. 2025 )
=-1*53.256/-28.62
=1.86

Sihuan Pharmaceutical Holdings Group's Interest Coverage for the quarter that ended in Dec. 2025 is calculated as

Here, for the six months ended in Dec. 2025, Sihuan Pharmaceutical Holdings Group's Interest Expense was $-13.7 Mil. Its Operating Income was $31.3 Mil. And its Long-Term Debt & Capital Lease Obligation was $104.3 Mil.

Interest Coverage=-1* Operating Income (Q: Dec. 2025 )/Interest Expense (Q: Dec. 2025 )
=-1*31.326/-13.716
=2.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.

Frequently Asked Questions Learn more about Interest Coverage →
What does a Interest Coverage of 2.28 mean?
Sihuan Pharmaceutical Holdings Group (SHPHF) has a Interest Coverage of 2.28 as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Sihuan Pharmaceutical Holdings Group and its competitors. This is 99% below median its historical median of 275.67. Over the past decade, Sihuan Pharmaceutical Holdings Group's Interest Coverage has ranged from 1.86 to 30,529.29. According to the industry distribution chart, Sihuan Pharmaceutical Holdings Group ranks #593 out of 685 companies in the Drug Manufacturers industry, placing it in the top 86.6%.
Is Sihuan Pharmaceutical Holdings Group's Interest Coverage too high?
Sihuan Pharmaceutical Holdings Group's current Interest Coverage of 2.28 is 99% below median its 10-year median of 275.67. Over the past 10 years, this metric has ranged from a low of 1.86 to a high of 30,529.29. The Drug Manufacturers industry median Interest Coverage is 12.78. Sihuan Pharmaceutical Holdings Group's value of 2.28 is 82.2% below this industry median. Based on the distribution chart, Sihuan Pharmaceutical Holdings Group ranks #593 out of 685 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Sihuan Pharmaceutical Holdings Group has a GF Score™ of 52/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sihuan Pharmaceutical Holdings Group's Interest Coverage compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Sihuan Pharmaceutical Holdings Group ranks #593 out of 685 companies for Interest Coverage. This places Sihuan Pharmaceutical Holdings Group in the lower half of its industry. The industry median Interest Coverage is 12.78. Sihuan Pharmaceutical Holdings Group's value of 2.28 is 82.2% below this benchmark. Historically, Sihuan Pharmaceutical Holdings Group's own Interest Coverage has ranged from 1.86 to 30,529.29 over the past decade. While the company's 10-year median is 275.67 vs. the industry median of 12.78, Sihuan Pharmaceutical Holdings Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.78, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sihuan Pharmaceutical Holdings Group's current Interest Coverage of 2.28 is 82.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Sihuan Pharmaceutical Holdings Group and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sihuan Pharmaceutical Holdings Group's current Interest Coverage is 2.28, which is 99% below median its own 10-year median of 275.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sihuan Pharmaceutical Holdings Group stock overvalued right now?
Based on GuruFocus' analysis, Sihuan Pharmaceutical Holdings Group (SHPHF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.17, compared to a current price of $0.13 — trading 23.7% below its estimated fair value. The current Interest Coverage is 2.28, which is 99% below median its 10-year median of 275.67 and 82.2% below the Drug Manufacturers industry median of 12.78. Sihuan Pharmaceutical Holdings Group's overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Sihuan Pharmaceutical Holdings Group (SHPHF), the current Interest Coverage is 2.28 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sihuan Pharmaceutical Holdings Group (SHPHF) Overvalued in 2026?

Based on GuruFocus' analysis, Sihuan Pharmaceutical Holdings Group stock appears to be undervalued. The current stock price of $0.13 is trading 23.7% below its estimated GF Value™ of $0.17. GuruFocus considers Sihuan Pharmaceutical Holdings Group to be Modestly Undervalued.

Key valuation signals for SHPHF:

  • Interest Coverage: 2.28 (99% below median its 10-year median of 275.67)
  • GF Value™: $0.17 vs. price of $0.13 (23.7% below fair value)
  • GF Score™: 52/100 with 4 warning signs
  • Industry Position: 82.2% below the Drug Manufacturers median (#593 of 685)

No single metric tells the full story. See the SHPHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sihuan Pharmaceutical Holdings Group Business Description

Other Exchanges 00460:Hong KongTEL1:Germany
Address 1 Harbour Road, Convention Plaza, Room 4905, Office Tower, Wanchai, HKG
Sihuan Pharmaceutical Holdings Group Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in the research & development and the manufacture & sale of pharmaceutical products. Its portfolio comprises products for diseases related to the cardio-cerebral vascular (CCV) system, Respiratory, Neurology, and others. The group has three reportable segments: the medical aesthetic products segment, including the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skincare, and others; the innovative medicine and other medicine segment; and the generic medicine segment, which generates key revenue. Geographically, the company generates a majority of its revenue from Mainland China and the rest from the United States.
52GF Score

Get the complete analysis for SHPHF

Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.13
Price
$0.17
GF Value